Skip to main content
SpringerLink
Log in

Zur Pathogenese und Pathophysiologie der essentiellen Hypertonie

  • Chapter
Arterielle Hypertonie

  • 37 Accesses

Zusammenfassung

Wenn auch signifikante Fortschritte im Verständnis der Mechanismen sekundärer Hypertonieformen gemacht wurden, bleibt doch die Ätiologie der essentiellen Hypertonie ein Rätsel. Die Bezeichnung „essentiell“ ist falsch. Irrtümlicherweise glaubte man, der erhöhte Blutdruck sei „essentiell“, um eine adäquate Gewebeperfusion bei Hypertonikern zu gewährleisten. Da die auslösende Ursache der essentiellen Hypertonie nicht erwiesen ist, wäre „idiopathische“ Hypertonie eine bessere Bezeichnung. 90% der Hypertoniker mit systolischer und diastolischer Druckerhöhung haben diese Hypertonieform.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Aars H (1968) Aortic baroreceptor activity in normal hypertensive rabbits. Acta Physiol Scand 72: 298–309

    Article  PubMed  CAS  Google Scholar 

  2. Abboud FM (1974) Effects of sodium, angiotensin, and steroids on the vascular reactivity in man. Fed Proc 33: 143–149

    PubMed  CAS  Google Scholar 

  3. Ahrens RA (1974) Sucrose hypertension and heart disease; an historical perspective. Am J Clin Nutr 27: 403–422

    PubMed  CAS  Google Scholar 

  4. Aiken JW (1974) Effects of prostaglandin synthesis inhibitors on angiotensin tachyphylaxis in the isolated coeliac and mesenteric arteries of the rabbit. Pol J Pharmacol Pharm 26: 217–227

    Article  PubMed  CAS  Google Scholar 

  5. Aiken JW, Vane JR (1973) Intrarenal prostaglandin release attenuates the renal vasoconstrictor activity of angiotensin. J Pharmacol Exp Ther 184: 678–687

    PubMed  CAS  Google Scholar 

  6. Alexandre JM, London GM, Chevillard C, Le-moire P, Safar ME, Weiss Y (1975) The meaning of dopamine-ß-hydroxylase in essential hypertension. Clin Sci Mol Med 49: 573–579

    PubMed  CAS  Google Scholar 

  7. Allen FM, Sherrill JW (1922) The treatment of arterial hypertension. J Metabol Research 2: 429–545

    Google Scholar 

  8. Aronow WS, Goldsmith JR, Kern JC, Cassidy J, Nelson WH, Johnson LL, Adams W (1974) Effect of smoking cigarettes on cardiovascular hemodynamics. Arch Environ Health 28: 330–332

    PubMed  CAS  Google Scholar 

  9. Ashley FM Jr, Kannel WB (1974) Relation of weight change to changes in atherogenic traits: The Framingham Study. J Chron Dis 27: 103–114

    Google Scholar 

  10. Axelrod J (1963) The formation, metabolism, uptake and release of noradrenaline and adrenaline. In: Variey H, Goweniock AH (eds) Symposium on the clinical chemistry of monoamines. Elsevier, Amsterdam, pp 5–18

    Google Scholar 

  11. Ayman D, Goldshine AD (1940) Blood pressure determinations by patients with essential hypertension. I. The difference between clinic and home readings before treatment. Am J Med Sci 220: 465–474

    Google Scholar 

  12. Ball JH, Kaminsky NI, Hardman JG, Broadus AE, Sutherland EW, Liddle GW (1972) Effects of catecholamines and adrenergic-blocking agents on plasma and urinary cyclic nucleotides in man. J Clin Invest 51: 2124–2129

    Article  PubMed  CAS  Google Scholar 

  13. Barrientos A, Alcazar JM, Ruilope LM, Fernandez-Tresguerres J, Garcia Robles R, Jarillo MD, Rodicio JL (1978) Effects of indomethacin in essential hypertension (abstr.) Internat Soc Hypertension, Fifth Scientific Meeting, p 25

    Google Scholar 

  14. Beevers DG, Campbell BC, Goldberg A, Moore MR, Hawthorne VM (1976) Blood-cadmium in hypertensives and normotensives. Lancet 2: 1222–1224

    Article  PubMed  CAS  Google Scholar 

  15. Beevers DG, Erskine E, Robertson M (1976) Blood-lead and hypertension. Lancet 2: 1–3

    PubMed  CAS  Google Scholar 

  16. Beilin LJ, Ziakas G (1971) Vascular reactivity in post desoxycorticosterone hypertension in rats and its relation to „irreversible“ hypertension in man. Clin Sci 42: 579–590

    Google Scholar 

  17. Bello CT, Sevy RW, Harakal C (1965) Varying hemodynamic patterns in essential hypertension. Am J Med Sci 250: 24–35

    Article  PubMed  CAS  Google Scholar 

  18. Bello CT, Sevy RW, Harakal C, Hillyer PN (1967) Relationship between clinical severity of disease and hemodynamic patterns in essential hypertension. Am J Med Sci 253: 194–208

    Article  PubMed  CAS  Google Scholar 

  19. Bengis RG, Coleman TG, Young DB, McCaa RE (1978) Long term blockade of angiotensin formation in various normotensive and hypertensive rat models using converting enzyme inhibitor. Circ Res 43 (Suppl I): 45–53

    CAS  Google Scholar 

  20. Bevan AT, Honour AI, Stott FH (1969) Direct arterial pressure recording in unrestricted man. Clin Sci 36: 329–344

    PubMed  CAS  Google Scholar 

  21. Bickerton RK, Buckley JP (1961) Evidence for a central mechanism in angiotensin induced hypertension. Proc Soc Biol Med 106: 834–836

    CAS  Google Scholar 

  22. Bierenbaum ML, Fleischman AI, Dunn J, Arnold J (1975) Possible toxic water factor in coronary heart disease. Lancet 1: 1008–1010

    Article  PubMed  CAS  Google Scholar 

  23. Bing RF, Russell GI, Thurston H, Sweles JD, Leicester UK (1980) Long term angiotensin blockade in conscious hypertensive rats: comparison with unclipping. Internat Soc Hypertension. Seventh Scientific Meeting, Abstr 12

    Google Scholar 

  24. Birkenhäger WH, Van Es LS, Houwing A, Lamers HJ, Mulder AH (1968) Studies on the lability of hypertension in man. Clin Sci 35: 445–456

    PubMed  Google Scholar 

  25. Birkenhäger WH, Schalekamp MHDH, Krass XH, Kolsters G, Zaal GA (1972) Consecutive haemodynamic patterns in essential hypertension. Lancet 1: 560–564

    Article  PubMed  Google Scholar 

  26. Biron P, Mongeau J-G, Bertrand D (1975) Familial aggregation of blood pressure in adopted and natural children. In: Paul O (ed) Epidemiology and control of hypertension. Stratton Intercontinental Medical Book Corp, New York, pp 397–404

    Google Scholar 

  27. Blaustein MP (1977) Sodium ions, calcium ions, blood pressure regulation, and hypertension: reassessment and a hypothesis. Am J Physiol 232: C165–173

    PubMed  CAS  Google Scholar 

  28. Bohr DF, Berecek KH (1976) Relevance of vascular structural and smooth muscle sensitivity changes in hypertension. Aust N Z J Med 6 (Suppl 2): 26–34

    Article  PubMed  Google Scholar 

  29. Boucher R, Demassieux S, Garcia R, Genest J (1977) Tonin-angiotensin II system. Chap 6.11 in: Genest J, Koiw E, Kuchel O (eds) Hypertension: physiopathology and treatment. McGraw-Hill, New York, pp 256–260

    Google Scholar 

  30. Boyle E Jr (1970) Biological patterns in hypertension by race, sex, body weight, and skin color. JAMA 213: 1637–1643

    Article  PubMed  Google Scholar 

  31. Braun-Menéndez E, Fasciolo JC, Leloir LF, Munoz JM (1940) Pharmacology of hypertension. Rev Soc Argent Biol 16: 398–410

    Google Scholar 

  32. Brunner HR, Laragh JH, Baer L, Newton MA, Goodwin FT, Krakoff LR, Bard RH, Bühler FR (1972) Essential hypertension: renin and aldosterone, heart attack and stroke. N Engl J Med 286: 441–449

    Article  PubMed  CAS  Google Scholar 

  33. Brunner HR, Sealey JE, Laragh JH (1973) Renin as a risk factor in essential hypertension. Am J Med 55: 295–302

    Article  PubMed  CAS  Google Scholar 

  34. Brunner HR, Sealey JE, Laragh JH (1973) Renin subgroups in essential hypertension. Further analysis of their pathophysiological and epidemiological characteristics. Circ Res 32 and 33 (Suppl I): 99–109

    Google Scholar 

  35. Bulpitt CJ, Hoffbrand BI, Dollery CT (1976) Psychological features of patients with hypertension attending hospital follow-up clinics. J Psychosom Res 20: 403–410

    Article  PubMed  CAS  Google Scholar 

  36. Canessa M, Adragna N, Solomon HS, Connolly TM, Tosteson DC (1980) Increased sodium-lithium countertransport in red cells of patients with essential hypertension. N Engl J Med 302: 772–776

    Article  PubMed  CAS  Google Scholar 

  37. Carney S, Morgan T, Wilson M, Matthews G, Roberts R (1975) Sodium restriction and thiazide diuretics in the treatment of hypertension. Med J Aust 1: 803–807

    PubMed  CAS  Google Scholar 

  38. Case DB, Casarella WJ, Hassar M, Laragh JH, Cannon PJ (1972) Renal circulation and renal secretion in normal and low essential hypertension. Circ 45 and 46 (Suppl II ) (abstr): 137

    Google Scholar 

  39. Case DB, Wallace JM, Keim HJ, Weber MA, Sealey JE, Laragh JH (1977) Possible role of renin in hypertension as suggested by reninsodium profiling and inhibition of converting enzyme. N Engl J Med 296: 641–646

    Article  PubMed  CAS  Google Scholar 

  40. Casell J (1974) Hypertension and cardiovascular disease in migrants: a potential source of clues? Int J Epidemiol 3: 204–205

    Article  Google Scholar 

  41. Chapnick BM, Paustian PW, Klainer E, Joiner PD, Hyman AL, Kadowitz PJ (1976) Influence of prostaglandins E, A and F on vasoconstrictor responses to norepinephrine, renal nerve stimulation and angiotensin in the feline kidney. J Pharmacol Exp Ther 916: 44–52

    Google Scholar 

  42. Chapnick BM, Paustian PW, Feigen LP, Joiner PD, Hyman AL, Kadowitz PJ (1977) Influence of inhibitors of prostaglandin synthesis on renal vascular resistance and on renal vascular responses to vasopressor and vasodilator agents in the cat. Circ Res 40: 348–354

    Article  PubMed  CAS  Google Scholar 

  43. Chernova NA, Nekrosova AA (1971) Urinary kallikrein in hypertensive vascular disease and renovascular hypertension (in Russian). Kardiologiia 11: 84–89

    PubMed  CAS  Google Scholar 

  44. Chiang BN, Perlman LV, Epstein FH (1969) Overweight and hypertension. A review. Circulation 39: 403–421

    Google Scholar 

  45. Christensen MS, Christensen NJ (1972) Plasma catecholamines in hypertension. Scand J Clin Lab Invest 30: 169–173

    Article  PubMed  CAS  Google Scholar 

  46. Cobb S, Rose RM (1973) Hypertension, peptic ulcer, and diabetes in air traffic controllers. JAMA 244: 489–492

    Article  Google Scholar 

  47. Coleman TG, Guyton AC (1969) Hypertension caused by salt loading in the dog. III. Onset transients of cardiac output and other circulatory variables. Circ Res 25: 153–160

    Google Scholar 

  48. Conway J (1963) A vascular abnormality in hypertension. A study of bloodflow in the forearm. Circulation 27: 520–529

    Article  PubMed  CAS  Google Scholar 

  49. Corcoran AC, Taylor RD, Page IH (1951) Controlled observations on the effect of low sodium dietotherapy in essential hypertension. Circulation 3: 1–16

    Article  PubMed  CAS  Google Scholar 

  50. Court JM, Hill GJ, Dunlop M, Boulton TJC (1974) Hypertension in childhood obesity. Aust Paediat J 10: 286–300

    Google Scholar 

  51. Cowley AW Jr, McCaa RE (1976) Acute and chronic dose-response relationships for angiotensin, aldosterone, and arterial pressure at varying levels of sodium intake. Circ Res 39: 788–797

    Article  PubMed  CAS  Google Scholar 

  52. Croxatto HR, Albertini R, Corthorn J, Rosas R (1977) Kallikrein and kinins in hypertension, Chap 8.1 in: Genest J, Koiw E, Kuchel O (eds) Hypertension: physiopathology and treatment. McGraw-Hill, New York, pp 364–373

    Google Scholar 

  53. Cryer PE, Haymond MW, Santiago JV, Shah SD (1976) Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med 295: 573–577

    Article  PubMed  CAS  Google Scholar 

  54. Crysant SG, Walsh GM, Kem DC, Frohlich ED (1979) Hemodynamic and metabolic evidence of salt sensitivity in spontaneously hypertensive rats. Kidney International 15: 33–37

    Article  Google Scholar 

  55. Cuche J-L, Kuchel O, Barbeau A, Langlois Y, Boucher R, Genest J (1974) Autonomic nervous system and benign essential hypertension in man. 1. Usual blood pressure, catecholamines, renin, and their interrelationships. Circ Res 35: 281–289

    Google Scholar 

  56. Dahl LK (1972) Salt and hypertension. Am J Clin Nutr 25: 231–244

    PubMed  CAS  Google Scholar 

  57. Dahl LK (1977) Salt intake and hypertension. Chap 12.2 in: Genest J, Koiw E, Kuchel O (eds) Hypertension: physiopathology and treatment. McGraw-Hill, New York, pp 548–559

    Google Scholar 

  58. Dahl LK, Heine M, Tassinari L (1962) Role of genetic factors in suspectibility to experimental hypertension due to chronic excess salt ingestion. Nature 194: 480–482

    Article  PubMed  CAS  Google Scholar 

  59. Dahl LK, Heine M, Tassinari L (1962) Effects of chronic excess salt ingestion. Evidence that genetic factors play an important role in susceptibility to experimental hypertension. J Exp Med 115: 1173–1190

    Google Scholar 

  60. Davis JO, Freeman RH (1976) Mechanisms regulating renin release. Physiological Reviews 56: 1–56

    PubMed  CAS  Google Scholar 

  61. de Champlain J (1977) The sympathetic system in hypertension. Clin Endocrinol Metab 6: 633–655

    Article  PubMed  Google Scholar 

  62. de Champlain J, Krakoff LR, Axelrod J (1968) Relationship between sodium intake and nor-epinephrine storage during the development of experimental hypertension. Circ Res 23: 479–491

    Article  Google Scholar 

  63. de Champlain J, Farley L, Cousineau D, van Amerigen M-R (1976) Circulating catecholamine levels in human and experimental hypertension. Circ Res 38: 109–114

    Article  PubMed  Google Scholar 

  64. DeQuattro V, Chan S (1972) Raised plasmacatecholamines in some patients with primary hypertension. Lancet 1: 806–809

    Article  PubMed  CAS  Google Scholar 

  65. De Simone A, Baer L (1978) Analysis of home and office blood pressures. Prey Med 7: (Abstr A-56) 60

    Google Scholar 

  66. Dickinson CJ, Lawrence JR (1963) A slowly developing pressor response to small concentrations of angiotensin; its bearing on pathogenesis of chronic renal hpyertension. Lancet 1: 1354–1356

    Article  PubMed  CAS  Google Scholar 

  67. Doyle AE (1977) Sympathetic nervous activity. In: Davis JO, Laragh JH, Selwyn A (eds) Hypertension: mechanisms, diagnosis and management. HP Publishing Co., New York, pp 201–209

    Google Scholar 

  68. Doyle AE (1977) Renin in hypertension: diagnostic and prognostic value. Chap 19 in: Genest J, Koiw E, Kuchel O (eds) Hypertension: physiopathology and treatment. McGraw-Hill, New York, pp 709–716

    Google Scholar 

  69. Doyle AE, Black H (1955) Reactivity to pressor agents in hypertension. Circulation 12: 974980

    Google Scholar 

  70. Doyle AE, Fraser JRE (1961) Essential hypertension and inheritance of vascular reactivity. Lancet 2: 509–511

    Article  PubMed  CAS  Google Scholar 

  71. Doyle AE, Fraser JRE (1961) Vascular reactivity in hypertension. Circ Res 9: 755–758

    Article  PubMed  CAS  Google Scholar 

  72. Doyle AE, Jerums G, Johnston CI, Louis WJ (1973) Plasma renin levels and vascular complications in hypertension. Br Med J 2: 206–207

    Article  PubMed  CAS  Google Scholar 

  73. Dustan HP, Tarazi RC, Frohlich ED (1970) Functional correlates of plasma renin activity in hypertensive patients. Circulation 41: 555–567

    Article  PubMed  CAS  Google Scholar 

  74. Dustan HP, Tarazi RC, Bravo EL, Dart RA (1973) Plasma and extracellular fluid volume in hypertension. Circ Res 32 and 33 (SupplI): 73–83

    Google Scholar 

  75. Dusting GJ, Moncada S, Vane JR (1977) Prostacyclin ( PGX) is the endogenous metabolite responsible for relaxation of coronary arteries induced by arachidonic acid. Prostaglandins 13: 3–15

    Google Scholar 

  76. Dworkin BR, Filewich RJ, Miller NE, Craigmyle N (1979) Baroreceptor activation reduces reactivity to noxious stimulation: Implications for hypertension. Science 205: 1299–1301

    Google Scholar 

  77. Dyer AR, Stamler J, Shekelle RB, Schoenberger J (1976) The relationship of education to blood pressure. Findings on 40,000 employed Chicagoans. Circulation 54: 987–992

    Article  PubMed  CAS  Google Scholar 

  78. Eich RH, Peters RJ, Cuddy RP, Smulyan H, Lyons RH (1962) The hemodynamics in labile hypertension. Am Heart J 63: 188–195

    Article  PubMed  CAS  Google Scholar 

  79. Eich RH, Cuddy RP, Smulyan H, Lyons RH (1966) Hemodynamics in labile hypertension. A follow-up study. Circulation 34: 299–307

    Google Scholar 

  80. Eide I, Kolloch R, de Quattro V, Miano L, bugger R, van der Muelen J (1979) Raised cerebrospinal fluid norepinephrine in some patients with primary hypertension. Hypertension 1: 255–260

    Article  PubMed  CAS  Google Scholar 

  81. Elliot AH, Nuzum FR (1934) The urinary excretion of a depressor substance (kallikrein of Frey and Kraut) in arterial hypertension. Endocrinology 18: 462–474

    Article  CAS  Google Scholar 

  82. Ellis CN, Julius S (1973) Role of central blood volume in hyperkinetic borderline hypertension. Brit Heart J 35: 450–455

    Article  PubMed  CAS  Google Scholar 

  83. Engelman K, Portnoy B, Sjoerdsma A (1970) Plasma catecholamine concentrations in patients with hypertension. Circ Res 27 (Suppl I): 141–146

    PubMed  CAS  Google Scholar 

  84. Erdös EG, Oshima G (1974) The angiotensin I converting enzyme of the lung and kidney. Acta Physiol Lat Am 24: 507–511

    PubMed  Google Scholar 

  85. Esler MD, Nestel PJ (1973) Renin and sympathetic nervous system responsiveness to adrenergic stimuli in essential hypertension. Am J Cardiol 32: 643–649

    Article  PubMed  CAS  Google Scholar 

  86. Esler MD, Nestel PJ (1973) High catecholamine essential hypertension: clinical and physiological characteristics. Aust NZ J Med 3: 117–123

    Article  CAS  Google Scholar 

  87. Esler MD, Nestel PJ (1973) Sympathetic responsiveness to head-up tilt in essential hypertension. Clin Sci 44: 213–226

    PubMed  CAS  Google Scholar 

  88. Esler MD, Julius S, Randal OS, Ellis CN, Kashima T (1975) Relation of renin status in neurogenic vascular resistance in borderline hypertension. Am J Cardiol 36: 708–715

    Article  PubMed  CAS  Google Scholar 

  89. Esler M, Julius S, Randall 0 (1976) Relationship of volume factors, renin and neurogenic resistance in borderline hypertension. In: Rorive G (ed) The arterial hypertensive disease. Masson, New York, pp 231–249

    Google Scholar 

  90. Esler M, Zweifler A, Randall O, Julius S, Bennett J, Rydelek P (1976) Suppression of sympathetic nervous function in low-renin essential hypertension. Lancet 2: 115–118

    Article  PubMed  CAS  Google Scholar 

  91. Esler M, Julius S, Zweifler A, Randall O, Harburg E, Gardiner H, de Quattro V (1977) Mild high renin essential hypertension. N Engl J Med 296: 405–411

    Article  PubMed  CAS  Google Scholar 

  92. Fasciolo JC, Houssay BA, Taquini AC (1938) The blood-pressure raising secretion of the ischaemic kidney. J Physiol (Lond) 94: 281–293

    CAS  Google Scholar 

  93. Feinlieb M (1977) Genetics and familial aggregation of blood pressure. Chap 4 in: Onesti G, Klimt CR (eds) Hypertension: determinants, complications, and intervention. The 5th Hahnemann international symposium on hyperten- sion. Grune and Stratton, New York, pp 35–48

    Google Scholar 

  94. Feinlieb M, Garrison R, Borhani N, Rosenman R, Christian J (1975) Studies of hypertension in twins. In: Paul O (ed) Epidemiology and control of hypertension. Stratton Intercontinental Medical Book Corp, New York, pp 3–17

    Google Scholar 

  95. Ferrario CM, Gildenberg PL, McCubbin JW (1972) Cardiovascular effects of angiotensin mediated by the central nervous system. Circ Res 30: 257–262

    Article  PubMed  CAS  Google Scholar 

  96. Fitzsimons JT, Simons BJ (1969) The effect on drinking in the rat of intravenous infusion of angiotensin, given alone or in combination with other stimuli of thirst. J Physiol 203: 45–57

    PubMed  CAS  Google Scholar 

  97. Folkow B (1971) The haemodynamic consequences of adaptive structural changes of the resistance of vessels in hypertension. Clin Sci 41: 1–12

    PubMed  CAS  Google Scholar 

  98. Folkow B (1975) Vascular changes in hypertension: Review and recent animal studies. In: Berglund C, Hanson L, Warkö L (eds) Pathophysiology and management of arterial hypertension. Lindgren A and Söner AB, Mölndal, Sweden, pp 95–113

    Google Scholar 

  99. Forsyth RP (1969) Blood pressure responses to longterm avoidance schedules in the restrained Rhesus monkey. Psychosomatic Med 31: 300–309

    CAS  Google Scholar 

  100. Fouad FM, Tarazi RC, Dustan HP, Bravo EL (1976) Hemodynamics of essential hypertension in adolescents (abstr). Circulation 54 (Suppl II): 24

    Google Scholar 

  101. Franco-Morcelli R, Elghozi JL, Joly E, di Giuilio S, Meyer P (1977) Increased plasma adrenaline concentrations in benign essential hypertension. Brit Med J 2: 1251–1254

    Article  Google Scholar 

  102. Franco-Morcelli R, Baudouin-Legros M, de Mendonça M, Guicheney P, Meyer P (1978) Plasma catecholamines in essential human hypertension and in DOCA-salt hypertension in the rat. Chap 5 in: Birkenhäger WH, Falke HE (eds) Circulating catecholamines and blood pressure. Bunge Scientific Publications, Utrecht, pp 27–38

    Google Scholar 

  103. Freeman RH, Davis JO, Lohmeier TE (1975) Des-l-asp-angiotensin II. Possible intrarenal role in homeostasis in the dog. Circ Res 37: 30–34

    Google Scholar 

  104. Friedman MJ, Bennett PL (1977) Depression and hypertension. Psychosom Med 39: 134–142

    PubMed  CAS  Google Scholar 

  105. Friedman R, Dahl LK (1975) The effect of chronic conflict on the blood pressure of rats with a genetic susceptibility to experimental hypertension. Psychosom Med 37: 402–416

    PubMed  CAS  Google Scholar 

  106. Friedman R, Iwai J (1976) Genetic predisposition and stress-induced hypertension. Science 193: 161–162

    Article  PubMed  CAS  Google Scholar 

  107. Friedman SM, Friedman CL (1976) Cell permeability, sodium transport and the hypertensive process in the rat. Circ Res 39: 433–441

    Article  PubMed  CAS  Google Scholar 

  108. Frohlich ED, Tarazi RC, Dustan HP (1969) Hyperdynamic (3-adrenergic circulatory state. Arch Int Med 123: 1–7

    Article  CAS  Google Scholar 

  109. Frohlich ED, Kozul VJ, Tarazi RC, Dustan HP (1970) Physiological comparison of labile and essential hypertension. Circ Res 27 (Suppl I): 55–63

    PubMed  CAS  Google Scholar 

  110. Garay RP, Meyer P (1979) A new test showing abnormal net Na+ and K+ fluxes in erythrocytes of essential hypertensive patients. Lancet I: 349–353

    Google Scholar 

  111. Gaskell P (1967) Digital vascular response to angiotensin II in normotensive and hypertensive subjects. Circ Res 20: 174–184

    Article  PubMed  CAS  Google Scholar 

  112. Geffen LB, Rush RA, Louis WJ, Doyle AE (1973) Plasma dopamine-13-hydroxylase and noradrenaline amounts in essential hypertension. Clin Sci 44: 617–620

    PubMed  CAS  Google Scholar 

  113. Genest J (1977) Basic mechanisms of essential hypertension. Chap 12.3 in: Genest J, Koiw E, Kuchel O (eds) Hypertension. McGraw-Hill, New York, pp 559–566

    Google Scholar 

  114. Genest J, Boucher R, Kuchel O, Nowaczynski W (1973) Renin in hypertension: how important as a risk factor? Can Med Assoc J 209: 475–478

    Google Scholar 

  115. Gitlow SE, Mendlowitz M, Wilk EK, Wilk S, Wolf RL, Naftchi NE (1964) Plasma clearance of dl-H3-norepinephrine in normal human subjects and patients with essential hypertension. J Clin Invest 43: 2009–2015

    Article  PubMed  CAS  Google Scholar 

  116. Gitlow SE, Mendlowitz M, Bertani LM, Wilk EK, Glabman S (1969) Tritium excretion of normotensive and hypertensive subjects after administration of tritiated norepinephrine. J Lab Clin Med 73: 129–134

    PubMed  CAS  Google Scholar 

  117. Gitlow SE, Dziedzic LM, Dziedzic SW, Wong BL (1976) Influence of ethanol on human catecholamine metabolism. Ann NY Acad Sci 273: 263–279

    Article  PubMed  CAS  Google Scholar 

  118. Glauser SC, Bello CT, Glauser EM (1976) Blood cadmium levels in normotensive and untreated hypertensive humans. Lancet 1: 717–718

    Article  PubMed  CAS  Google Scholar 

  119. Goldenberg M, Pines KL, Bladwin E, De F, Green DG, Roh CE (1948) The hemodynamic response of man to norepinephrine and epinephrine and its relation to the problem of hypertension. Am J Med 5: 792–806

    Article  PubMed  CAS  Google Scholar 

  120. Gorlin R (1962) The hyperkinetic heart syndrome. JAMA 182: 823–829

    Article  PubMed  CAS  Google Scholar 

  121. Gribbin B, Pickering TG, Sleight P, Peto R (1971) Effect of age and high blood pressure on baroreflex sensitivity in man. Circ Res 29: 424–431

    Article  PubMed  CAS  Google Scholar 

  122. Grim CE, McDonough JR, Dahl LK, Hames CG (1970) Dietary sodium, potassium and blood pressure: 300 racial differences in Evans County. Georgia (abstr). Circulation 41 and 42 (Suppl III): 85

    Google Scholar 

  123. Grollman A (1953) Effect of increasing the extracellular fluid volume on the arterial blood pressure of the normal, hypertensive and nephrectomized dog. Am J Physiol 173: 364 370

    Google Scholar 

  124. Grollman A, Williams JR Jr, Harrison TR (1940) The preparation of renal extracts capable of reducing the blood pressure of animals with experimental renal hypertension. J Biol Chem 134: 115–121

    CAS  Google Scholar 

  125. Gulati SC, Adlin EV, Biddle CM, Marks AD Channick BJ (1973) The occurrence of vascular complications of low renin hypertension. Ann Intern Med 78: 828

    Google Scholar 

  126. Guyton AC, Coleman TG (1969) Quantitative analysis of the pathophysiology of hypertension. Circ Res 24 (Suppl I): 1–19

    Article  PubMed  CAS  Google Scholar 

  127. Guyton AC, Coleman TG, Cowley AW Jr, Scheel KW, Manning RD Jr, Norman RA Jr (1973) Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension. In: Laragh JH (ed) Hypertension manual. Dun-Donnelley, New York, pp 111–134

    Google Scholar 

  128. Haddy F, Pamnani M, Clough D (1978) Review: The sodium-potassium pump in volume expanded hypertension. Clin Exp Hypertension 1: 295–336

    Google Scholar 

  129. Haddy FJ, Pamnani MB, Clough DL (1979) Minireview: humoral factors and the sodium-potassium pump in volume expanded hypertension. Life Sciences 24: 2105–2118

    Article  PubMed  CAS  Google Scholar 

  130. Hallbäck M, Folkow B (1974) Cardiovascular responses to acute mental „stress“ in spontaneously hypertensive rats. Acta Physiol Scand 90: 684–698

    Article  PubMed  Google Scholar 

  131. Hamilton JG, Grollman A (1958) The preparation of renal extracts effective in reducing blood pressure in experimental hypertension. J Biol Chem 233: 528–529

    PubMed  CAS  Google Scholar 

  132. Harburg E, Erfurt JC, Chape C, Hauenstein LS, Schull WJ, Schork MA (1973) Socioecological stressor areas and black-white blood pressure: Detroit. J Chron Dis 26: 595–611

    Google Scholar 

  133. Harris AH, Gilliam WJ, Findley JD, Brady JV (1973) Instrumental conditioning of large-magnitude, daily, 12-hour blood pressure elevations in the baboon. Science 182: 175–177

    Article  PubMed  CAS  Google Scholar 

  134. Harris GS (1970) A relationship among arterial wall acid mucopolysaccharides, cation binding, and arterial reactivity. Circ Res 26 and 27 (Suppl II): 91

    Google Scholar 

  135. Harris GS (1975) Relationship between body sodium and arterial pressure. Clin Exp Pharmacol Physiol (Suppl 2 ): 123–126

    CAS  Google Scholar 

  136. Hedqvist P (1970) Studies on the effect of Prostaglandins E1 and E2 on the sympathetic neuromuscular transmission in some animal tissues. Acta Physiol Scand (Suppl) 345: 1–40

    CAS  Google Scholar 

  137. Heinemann HO, Lee JB (1976) Prostaglandins and blood pressure control. Am J Med 61: 681–695

    Article  PubMed  CAS  Google Scholar 

  138. Hennekens CH, Jesse MJ, Klein BE, Gourlag JE, Blumenthal S (1976) Sibling aggregation of blood pressure: nature or nurture? Prey Med 5 (1): 60–62

    Article  CAS  Google Scholar 

  139. Henry DP, Friedrich CL, Weinberger MH, Feinberg NS, Grim CE (1980) Norepinephrine in urine and plasma following provocative maneuvers in normal and hypertensive subjects. Hypertension 2: 20–28

    Article  PubMed  CAS  Google Scholar 

  140. Henry JP, Stephens PM (1977) Stress, health, and the social environment. A sociobiologic approach to medicine. Springer-Verlag, New York, p 282

    Chapter  Google Scholar 

  141. Henry JP, Stephens PM, Santistenban GA (1975) A model of psychosocial hypertension showing reversibility and progression of cardiovascular complications. Circ Res 36: 156–164

    Article  PubMed  CAS  Google Scholar 

  142. Hickler RB, Lauler DP, Saravis CA, Vagnucci AI, Steiner G, Thorn GW (1964) Vasodepressor lipid from the renal medulla. Can Med Assoc J 90: 280–287

    PubMed  CAS  Google Scholar 

  143. Hines EA (1940) The significance of vascular hyperreaction as measured by the cold pressor test. Am Heart J 19: 408–416

    Article  Google Scholar 

  144. Hines EA (1951) Vascular reactivity and hypertensive disease. In: Bell ET (ed) Hypertension. University of Minnesota Press, Minneapolis, pp 331–341

    Google Scholar 

  145. Hong Tai Eng FW, Huber-Smith M, McCann DS (1980) The role of sympathetic activity in normal renin essential hypertension. Hypertension 2: 14–19

    Article  Google Scholar 

  146. Horwitz D, Alexander RW, Lovenberg W, Keiser HR (1973) Human serum dopamine-ßhydroxylase. Relationship to hypertension and sympathetic activity. Circ Res 32: 594–599

    Google Scholar 

  147. Horwitz D, Clineschmidt BV, Van Buren JM, Ommaya AK (1974) Temporal arteries from hypertensive and normotensive man. Circ Res 34 and 35 (Suppl I): 109–122

    Google Scholar 

  148. Ibrahim MM, Tarazi RC, Dustan HP, Bravo EL (1974) Cardiovascular factor in essential hypertension. Am Heart J 88: 724–732

    Article  PubMed  CAS  Google Scholar 

  149. Ibrahim MM, Tarazi RC, Dustan HP, Bravo EL, Gifford RW Jr (1975) Hyperkinetic heart in severe hypertension: A separate clinical hemodynamic entity. Am J Cardiol 35: 667–674

    Google Scholar 

  150. Iversen LL (1975) Uptake of circulating catecholamines in tissues. In: Blaschko H, Sayers G, Smith DA (eds) Adrenal gland. Handbook of physiology, vol VI, sect 7, Endocrinology. Am Physiol Soc, Washington DC, pp 713–722

    Google Scholar 

  151. Iwai J, Knudsen KD, Dahl LK, Heine M, Leitl G (1969) Genetic influence on the development of renal hypertension in parabiotic rats. Evidence for a humoral factor. J Exp Med 129: 507–522

    Google Scholar 

  152. Johnson AL, Cornoni JC, Cassel JC, Tyroler HA, Heyden S, Hames CG (1975) Influence of race, sex and weight on blood pressure behavior in young adults. Am J Cardiol 35: 523–530

    Article  PubMed  CAS  Google Scholar 

  153. Johnston CI, Mendelsohn FAD, Doyle AE (1972) Metabolism of angiotensin II in sodium depletion and hypertension in humans. Circ Res 30 and 31 (Suppl II): 203–213

    Google Scholar 

  154. Jonsson A, Hansson L (1977) Prolonged exposure to a stressful stimulus (noise) as a cause of raised blood pressure in man. Lancet 1: 86–87

    Article  Google Scholar 

  155. Julius S, Conway J (1968) Hemodynamic studies in patients with borderline blood pressure elevation. Circulation 38: 282–288

    Article  PubMed  CAS  Google Scholar 

  156. Julius S, Esler M (1975) Autonomic nervous and cardiovascular regulation in borderline hypertension. Am J Cardiol 36: 685–696

    Article  PubMed  CAS  Google Scholar 

  157. Julius S, Ellis CN, Pascual AV, Matice M, Hans-son L, Hunyor SN, Sandler LN (1974) Home blood pressure determination. Value in borderline („labile“) hypertension. JAMA 229: 663–670

    Google Scholar 

  158. Julius S, Esler M, Randall 0 (1974) Neurogenic borderline hypertension (abstr). Circulation 50 (Suppl III): 107

    Google Scholar 

  159. Julius S, Esler MD, Randall OS (1975) Role of the autonomic nervous system in mild human hypertension. Clin Sci Mol Med 48 (Suppl): 243s - 252s

    Google Scholar 

  160. Julius S, Randall OS, Esler MD, Kasima T, Ellis C, Bennett J (1975) Altered cardiac responsiveness and regulation in the normal cardiac output type of borderline hypertension. Circ Res 36 and 37 (Suppl I): 199–207

    Article  Google Scholar 

  161. Kannel WB (1971) Current state of the epidemiology of brain infarction associated with occlusive arterial disease. Stroke 2: 295–318

    Article  PubMed  CAS  Google Scholar 

  162. Kannel WB, Sorlie P (1975) Hypertension in Framingham. In: Paul O (ed) Epidemiology and control of hypertension. Stratton Intercontinental Medical Book Corp, New York, pp 553–587

    Google Scholar 

  163. Kannel WB, Brand N, Skinner JJ, Dawber TR, McNamara PM (1967) The relation of adiposity to blood pressure and development of hypertension. Ann Intern Med 67: 48–59

    PubMed  CAS  Google Scholar 

  164. Kannel WB, Castelli WP, McNamara PM, Sorlie P (1969) Some factors affecting morbidity and mortality in hypertension. The Framingham Study. Midbank Memorial Fund Q 47, no 3, part 2: 116–142

    Article  Google Scholar 

  165. Kannel WB, Gordon T, Schwartz MJ (1971) Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham Study. Am J Cardiol 27: 335–346

    Google Scholar 

  166. Kaplan NM (1975) The prognostic implications of plasma renin in essential hypertension. JAMA 231: 167–170

    Article  PubMed  CAS  Google Scholar 

  167. Kaplan NM (1978) Clinical hypertension, 2nd ed. Williams and Wilkins, Baltimore, 405 pp

    Google Scholar 

  168. Kaplan NM, Silah JG (1964) The angiotensininfusion test. A new approach to the differential diagnosis of renovascular hypertension. N Engl J Med 271: 536–541

    Google Scholar 

  169. Kaplan NM, Silah JG (1964) The effect of angiotensin II on the blood pressure in humans with hypertensive disease. J Clin Invest 43: 659–669

    Article  PubMed  CAS  Google Scholar 

  170. Kass EH, Zinner SH, Margolius HS, Lee Y, Rosner B, Donner H (1975) Familial aggregation of blood pressure and urine kallikrein in early childhood. In: Paul O (ed) Epidemiology and control of hypertension. Stratton Intercontinental Medical Book Corp, New York, pp 359–374

    Google Scholar 

  171. Kempner W (1944) Treatment of kidney disease and hypertensive vascular disease with rice diet. N C Med J 5: 125–133

    Google Scholar 

  172. Kempner W (1948) Treatment of hypertensive vascular disease with the rice diet. Am J Med 4: 545–577

    Article  PubMed  CAS  Google Scholar 

  173. Keys A, Aravanis C, Blackburn H, van Buchem FSP, Buzina R, Djordjevic BS, Fidanza F, Karvonen MF, Menotti A, Pudda V, Taylor HL (1972) Coronary heart disease: overweight and obesity as risk factors. Ann Intern Med 77: 15–27

    PubMed  CAS  Google Scholar 

  174. Khosla MC, Page IH, Bumpus FM (1979) Interrelations between various blood pressure regulatory systems and the mosaic theory of hypertension. Biochem Pharmacol 28: 2867–2882

    Article  PubMed  CAS  Google Scholar 

  175. Kisch ES, Dluhy RG, Williams GH (1976) Enhanced aldosterone response to angiotensin II in human hypertension. Circ Res 38: 502–505

    Article  PubMed  CAS  Google Scholar 

  176. Klatsky AL, Friedman GD, Sieglaub AB, Gerard MJ (1977) Alcohol consumption and blood pressure. N Engl J Med 296: 1194–1200

    Article  PubMed  CAS  Google Scholar 

  177. Kopin IJ, Kaufman S, Viveros H, Jacobowitz D, Lake R, Ziegler MG, Lovenburg W, Goodwin FK (1976) Dopamine-ß-hydroxylase. Basic and clinical studies. Ann Intern Med 85: 211–223

    Google Scholar 

  178. Korner PI, Fletcher PJ (1977) Role of the heart in causing and maintaining hypertension. Cardiovasc Med 2: 139–155

    Google Scholar 

  179. Kuchel O (1976) Adrenergic reactivity in low renin and normal renin essential hypertension. Circ Res 39: 289–290

    Article  PubMed  CAS  Google Scholar 

  180. Kuchel 0 (1977) Autonomic nervous system in hypertension: clinical aspects. Chap 5.3 in: Genest J, Koiw E, Kuchel O (eds) Hypertension: physiopathology and treatment. McGraw-Hill, New York, pp 93–114

    Google Scholar 

  181. Kuchel O (1980) In discussion. In: Hunt JC, Cooper T, Frohlich ED, Gifford RW Jr, Kaplan NM, Laragh JH, Maxwell MH, Strong CG (eds) Dialogues in hypertension. Hypertension update: mechanisms, epidemiology, evaluation, management. Health Learning Systems, Bloomfield, NJ, pp 131–132

    Google Scholar 

  182. Kuchel O, Cuche JL, Barbeau A, Hamet P, Boucher R, Nowaczynski W, Genest J (1970) Low grade hypertension and fl-adrenergic hyperactivity: two extreme poles of essential hypertension. Circulation 42 (Suppl III ) (abstr): 70

    Google Scholar 

  183. Kuchel 0, Cuche JL, Hamet P, Boucher R, Barbeau A, Genest J (1972) The relationship between adrenergic nervous system and renin in labile hyperkinetic hypertension. In: Genest J, Koiw E (eds) Hypertension. Springer-Verlag, New York, pp 118–125

    Google Scholar 

  184. Kuchel O, Cuche JL, Hamet P, Tolis G, Masserli FH, Barbeau A, Boucher R, Genest J (1975) Labile (borderline) hypertension - new aspects of a common disorder. Angiology 26: 619631

    Google Scholar 

  185. Kuchel O, Buu NT, Hamet P, Guthrie GP Jr, Cuche JL, Boucher R, Genest J (1977) Catecholamines, cyclic AMP and renin in two contrasting forms of essential hypertension. Contrib Nephrol 8: 27–36

    PubMed  CAS  Google Scholar 

  186. Kuchel O, Buu NT, Unger T (1978) Dopamine-sodium relationship: is dopamine a part of the endogenous natriuretic system? Contrib Nephrol 13: 27–36

    PubMed  CAS  Google Scholar 

  187. Kunin CM, McCormack RC (1968) An epidemiologic study of bacteriurea and blood pressure among nuns and working women. N Engl J Med 278: 635–642

    Article  PubMed  CAS  Google Scholar 

  188. Kuschke HJ (1961) Investigation about the state of excitation of the sympathetic nervous system and the adrenal medulla in cardiovascular disease. Arch Kreislaufforsch 36: 104–148

    Article  PubMed  CAS  Google Scholar 

  189. Lake CR, Ziegler MG, Coleman M, Kopin IJ (1976) Plasma norepinephrine and dopaminebeta-hydroxylase in hypertension. Fed Proc 35 (abstr 1063): 398

    Google Scholar 

  190. Lake CR, Ziegler MG, Kopin IJ (1976) Use of plasma norepinephrine for evaluation of sympathetic neural function in man. Life Sciences 18: 1315–1326

    Article  PubMed  CAS  Google Scholar 

  191. Lake CR, Ziegler MG, Coleman MD, Kopin IJ (1977) Age adjusted plasma norepinephrine levels are similar in normotensive and hypertensive subjects. N Engl J Med 296: 208–209

    Article  PubMed  CAS  Google Scholar 

  192. Langford HG (1978) Salt and hypertension: discussion. In: Mild hypertension: to treat or not to treat. Ann N Y Acad Sci 304: 198–199

    Google Scholar 

  193. Laragh JH (1974) An approach to the classification of hypertensive states. Hosp Prac (Jan): 61–73

    Google Scholar 

  194. Laragh JH (1977) An approach to the classification of hypertensive states. Chap 1 in: Davis JO, Laragh JH, Selwyn A (eds) Hypertension: mechanisms, diagnosis and management. HP Publishing Co, New York, pp 1–13

    Google Scholar 

  195. Laragh JH (1977) Vasoconstriction-volume analysis in treatment of hypertension. Chap 7 in: Davis JO, Laragh JH, Selwyn A (eds) Hypertension: mechanisms, diagnosis and management. HP Publishing Co, New York, pp 69–79

    Google Scholar 

  196. Lauer RM, Filer LJ, Reiter MA, Clarke WR (1977) Blood pressure, salt preference, salt threshold, and relative weight. Am J Dis Childhood 130: 493–497

    Google Scholar 

  197. Lazarus JM, Hampers CL, Bennett AH, Vandam LD, Merrill JP (1972) Urgent bilateral nephrectomy for severe hypertension. Ann Intern Med 76: 733–739

    PubMed  CAS  Google Scholar 

  198. Lee JB (1967) Antihypertensive activity of the kidney–the renomedullary prostaglandins. N Engl J Med 277: 1073–1079

    Article  PubMed  CAS  Google Scholar 

  199. Lee JB (1974) Cardiovascular-renal effects of prostaglandins. Arch Intern Med 133: 56–76

    Article  PubMed  CAS  Google Scholar 

  200. Lee JB (1977) Prostaglandins, neutral lipids, renal interstitial cells, and hypertension. Chap 8.2 in: Genest J, Koiw E, Kuchel O (eds) Hypertension: physiopathology and treatment. McGraw-Hill, New York, pp 373–397

    Google Scholar 

  201. Lee JB, Hickler RB, Saravis CA, Thorn GW (1963) Sustained depressor effect of renal medullary extract in the normotensive rat. Circ Res 13: 359–366

    Article  PubMed  CAS  Google Scholar 

  202. Lee Y-H, Rosner B, Gould JG, Lowe EW, Kass EH (1976) Familial aggregation of blood pressures of newborn infants and their mothers. Pediatrics 58: 722–729

    PubMed  CAS  Google Scholar 

  203. Levine LS, Lewy JE, New MI (1976) Hypertension in high school students. NY State J Med 76: 40–44

    CAS  Google Scholar 

  204. Levy SB, Lilley JJ, Frigon RP, Stone RA (1977) Urinary kallikrein and plasma renin activity as determinants of renal blood flow. J Clin Invest 60: 129–138

    Article  PubMed  CAS  Google Scholar 

  205. Liard J-F, Tarazi RC, Ferrario CM, Manger WM (1975) Hemodynamic and humoral characteristics of hypertension induced by prolonged stellate ganglion stimulation in conscious dogs. Circ Res 36: 455–464

    Article  PubMed  CAS  Google Scholar 

  206. Loggie JMH (1975) Hypertension in children and adolescents. Hosp Practice 10 (6): 81–92

    Google Scholar 

  207. Londe S, Goldring D (1976) High blood pressure in children: problems and guidelines for evaluation and treatment. Am J Cardiol 37: 650–657

    Article  PubMed  CAS  Google Scholar 

  208. Londe S, Bourgoignie JJ, Robson AM, Goldring D (1971) Hypertension in apparently normal children. J Pediat 78: 569–577

    Article  PubMed  CAS  Google Scholar 

  209. Louis WJ, Tabei R, Spector S (1971) Effects of sodium intake and inherited hypertension in the rat. Lancet 2: 1283–1286

    Article  PubMed  CAS  Google Scholar 

  210. Louis WJ, Doyle AE, Anavekar S (1973) Plasma norepinephrine levels in essential hypertension. N Engl J Med 288: 599–601

    Article  PubMed  CAS  Google Scholar 

  211. Lowder SC, Hamet P, Liddle GW (1976) Contrasting effects of hypoglycemia on plasma renin activity and cyclic adenosine 3’,5’-monophosphate (cyclic AMP) in low renin and normal renin essential hypertension. Circ Res 38: 105–108

    Article  PubMed  CAS  Google Scholar 

  212. Lowenstein FW (1961) A study of blood pressure and body measurements in medical students in the Brazilian city of Belem. Cardiologia 39: 46–56

    Article  PubMed  CAS  Google Scholar 

  213. Lucas CP, Holzwarth GJ, Ocobock RW, Sozen T, Stern MP, Wood PDS, Haskell WL, Farquhar JW (1974) Disturbed relationship of plasmarenin to blood-pressure in hypertension. Lancet 2: 1337–1339

    Article  PubMed  CAS  Google Scholar 

  214. Luft F, Bloch R, Grim C, Henry D, Weinberger M (1978) Sympathetic nervous system activity (SNSA) and salt balance. J Clin Res 26: 365 A

    Google Scholar 

  215. Lundgren Y (1974) Regression of structural car diovascular changes after reversal of experiment tal renal hypertension in rats. Acta Physiol Scand 91: 275–285

    Article  PubMed  CAS  Google Scholar 

  216. Lund-Johansen P (1968) Hemodynamics in ear ly essential hypertension. Acta Med Scand 183 (Suppl 482): 1–101

    Google Scholar 

  217. Lund-Johansen P (1978) Spontaneous changes in central hemodynamics in essential hypertension: a 10-year follow-up study. In: Onesti G, Klimt R, Schaefer RI (eds) Hypertension: deter minants, complications and intervention. Grune and Stratton, New York, pp 201–209

    Google Scholar 

  218. Malik KU, Nasjletti A (1976) Facilitation of adrenergic transmission by locally generated angiotensin II in rat mesenteric arteries. Circ Res 38: 26–30

    Article  PubMed  CAS  Google Scholar 

  219. Manger WM, Gifford RW Jr (1977) Pheochro-mocytoma. Springer-Verlag, New York, p 3

    Book  Google Scholar 

  220. Manger WM, von Estorff I, Davis S, Chu D, Wakim K, Dufton S (1975) Inadequacy of plasma catecholamines as an index of adrenergic activity. Fed Proc 34 ( abstr 2853): 723

    Google Scholar 

  221. Manger WM, Frohlich ED, Gifford RW, Du- stan HP (1976) Norepinephrine infusion in nor mal subjects and patients with essential or renal hypertension: effect on blood pressure, heart rate, and plasma catecholamine concentrations. J Clin Pharmacol 16: 129–141

    Article  PubMed  CAS  Google Scholar 

  222. Manger WM, van Praag D, Weiss RJ, Hart CJ, Hulse M, Rock TW, Farber SJ (1976) Effect of transplanting renomedullary tissue into sponta neously hypertensive rats (SHR). Fed Proc 35 (abstr 1931): 556

    Google Scholar 

  223. Manthorpe T (1973) The effect on renal hyper tension of subcutaneous isotransplantation of renal medulla from normal or hypertensive rats. Acta Pathol Microbiol Scand 81 A: 725–733

    Google Scholar 

  224. Margolius HS, Geller R, Pisano JJ, Sjoerdsma A (1971) Altered urinary kallikrein excretion in human hypertension. Lancet 2: 1063–1065

    Article  Google Scholar 

  225. Margolius H, Horwitz D, Pisano J, Keiser H (1973) Urinary kallikrein and human hypertension: effects of salt and mineralocorticoids. Clin Res 21 (abstr): 699

    Google Scholar 

  226. Meneely GR (1978) Salt and hypertension: general discussion. In: Mild hypertension: to treat or not to treat. Ann NY Acad Sci 304: 201

    Google Scholar 

  227. Meneely GR, Battarbee HD (1976) High sodium-low potassium environment and hypertension. Am J Cardiol 38: 768–785

    Article  PubMed  CAS  Google Scholar 

  228. Margolius HS, Horwitz D, Pisano JJ, Keiser HR (1974) Urinary kallikrein excretion in hyperten sive man. Relationships to sodium intake and sodiumretaining steroids. Circ Res 35: 820–825

    Google Scholar 

  229. Margolius HS, Horwitz D, Pisano JJ, Keiser HR (1976) Relationships among urinary kallikrein, mineralocorticoids and human hypertensive disease. Fed Proc 35: 203–206

    PubMed  CAS  Google Scholar 

  230. Meneely GR, Tucker RG, Darby WJ, Auerbach SH (1953) Chronic sodium chloride toxicity in the albino rat. II. Occurrence of hypertension and a syndrome of edema and renal failure. J Exp Med 98: 71–80

    Google Scholar 

  231. Mark AL, Lawton WJ, Abboud FM, Fitz AE, Connor WE (1974) Effects of high and low sodium intake on blood pressure reactivity in borderline hypertensive subjects. Circulation 50 ( Suppl III): 107

    Google Scholar 

  232. Mark AL, Lawton WJ, Abboud FM, Fitz AE, Connor WE, Heistad DD (1975) Effects of high and low sodium intake on arterial pressure and forearm vascular resistance in borderline hyper-tension. A preliminary report. Clin Res 36 and 37 (Suppl I): 194–198

    Google Scholar 

  233. Mathews JD (1976) Alcohol usage as a possible explanation for socio-economic and occupational differentials in mortality from hypertension and coronary heart disease in England and Wales. Aust NZ J Med 6: 393–397

    Article  CAS  Google Scholar 

  234. Maxwell MH (1975) Cooperative study of renovascular hypertension: current status. Kidney Int 8 (Suppl 5): 153–160

    Google Scholar 

  235. McCubbin JW, Page I H (1963) Renal pressor system and neurogenic control of arterial blood pressure. Circ Res 12: 553–559

    Article  CAS  Google Scholar 

  236. McCubbin JW, Green JH, Page IH (1956) Baroreceptor function in chronic renal hypertension. Circ Res 4: 205–210

    Article  PubMed  CAS  Google Scholar 

  237. McCubbin JW, De Moura RJ, Page IH, Olmsted F (1965) Arterial hypertension elicited by subpressor amounts of angiotensin. Science 149: 1394–1395

    Article  PubMed  CAS  Google Scholar 

  238. McGiff JC, Nasjletti A (1976) Kinins, renal function and blood pressure regulation. Fed Proc 35: 172–174

    PubMed  CAS  Google Scholar 

  239. McGiff JC, Crowshaw K, Terragno NA, Lonigro AJ (1970) Renal prostaglandins: possible regulators of the renal actions of pressor hormones. Nature 227: 1255–1257

    Article  PubMed  CAS  Google Scholar 

  240. McGiff JC, Crowshaw K, Itskovitz HD (1974) Prostaglandins and renal function. Fed Proc 33: 39–47

    PubMed  CAS  Google Scholar 

  241. Mendlowitz M (1973) Vascular reactivity in systemic arterial hypertension. Am Heart J 85: 252–259

    Article  PubMed  CAS  Google Scholar 

  242. Mendlowitz M (1979) The many faces of hyper tension: environmental and genetic theories. Clin Exp Hypertension 1: 423–447

    Article  Google Scholar 

  243. Mendlowitz M, Naftchi N (1958) Work of digital vasoconstriction produced by infused norepi-nephrine in primary hypertension. J Appl Phy siol 13: 247–256

    CAS  Google Scholar 

  244. Mendlowitz M, Wolf RL, Gitlow SE (1970) Catecholamine metabolism in essential hypertension. Am Heart J 79: 401–407

    Article  PubMed  CAS  Google Scholar 

  245. Mersey JH, Williams GH, Hollenberg N K, Dluhy RG (1977) Relationship between aldosterone and bradykinin. Circ Res 40 and 41 (Suppl I): 84–88

    Google Scholar 

  246. Messerli FH, Genest J, Nowaczynski W, Kuchel O, Honda M, Latour Y, Dumont G (1975) Splanchnic blood flow in essential hypertension and in hypertensive patients with renal artery stenosis. Circulation 51: 1114–1119

    Article  PubMed  CAS  Google Scholar 

  247. Messerli FH, Kuchel O, Hamet P, Tolis G, Guthries GP Jr, Fraysee J, Nowaczynski W, Genest J (1976) Plasma cyclic adenosine 3’,5’monophosphate response to isoproterenol and glucagon in hyperkinetic borderline (labile) hypertension. Circ Res 38 (Suppl II): 42–47

    Article  PubMed  CAS  Google Scholar 

  248. Miall WE (1978) Genetic considerations concerning hypertension. In: Mild hypertension: to treat or not to treat. Ann NY Acad Sci 304: 18–27

    Google Scholar 

  249. Miall WE, Chinn S (1973) Blood pressure and aging; results of a 15–17 year follow-up study in South Wales. Clin Sci Mol Med 45 (Suppl I): 23–33

    Google Scholar 

  250. Michelakis AM, Caudle J, Liddle GW (1969) In vitro stimulation of renin production by epinephrine, norepinephrine and cyclic AMP. Proc Soc Exp Biol Med 130: 748–753

    PubMed  CAS  Google Scholar 

  251. Mitchell SC, Blount SG Jr, Blumenthal S, Hoffman JIE, Jesse MJ, Lauer RM, Weidman WH (1975) The pediatrician and hypertension. Pediatrics 56: 3–5

    PubMed  CAS  Google Scholar 

  252. Mitchell JR, Taylor AA, Pool JL, Lake CR, Rollins DE, Bartter FC (1977) Renin-aldosterone profiling in hypertension. Ann Intern Med 87: 596–612

    PubMed  CAS  Google Scholar 

  253. Molzahn M, Dissmann Th, Gotzen R, Lohmann FW (1971) The effects of acute and chronic diminution of cardiac output on blood pressure in early hypertension. Hemodynamic alterations after ß-receptor blockade. Klin Wochenschr 49: 476–484

    Google Scholar 

  254. Molzahn M, Dissmann TH, Halim S, Lohmann FW, Oelkers W (1972) Orthostatic changes of heamodynamics, renal function, plasma catecholamines and plasma renin concentration in normal and hypertensive man. Clin Sci 42: 209–222

    PubMed  CAS  Google Scholar 

  255. Morton WE, Knudsen JC (1975) Correlates of hypertension among young men. Prey Med 4: 258–267

    Article  CAS  Google Scholar 

  256. Mroczek WJ, Finnerty FA, Catt KJ (1973) Lack of association between plasma-renin and history of heart-attack or stroke in patients with essential hypertension. Lancet 2: 464–468

    PubMed  CAS  Google Scholar 

  257. Muehrcke RC, Mandai AK, Volini FI (1970) A pathophysiological review of the renal medullary interstitial cells and their relationship to hypertension. Circ Res 26 and 27 (Suppl I): 109–119

    Google Scholar 

  258. Muirhead EE (1977) The antihypertensive function of the renal medulla. Chap 14 in: Davis JO, Laragh JH, Selwyn A (eds) Hypertension: mechanisms, diagnosis and management. HP Publishing Co, New York, pp 145–156

    Google Scholar 

  259. Muirhead EE (1981) Antihypertensive functions of the kidney. In: The third Arthur C Corcoran memorial lecture. Hypertension 2: 444–464

    Google Scholar 

  260. Muirhead EE, Jones J, Graham P (1953) Hypertension in bilaterally nephrectomized dogs in the absence of exogenous sodium excess. Arch Pathol 56: 286–292

    CAS  Google Scholar 

  261. Muirhead EE, Germain G, Leach B, Pitcock JA, Stephenson P, Brooks B, Brosius WL, Daniels EG, Hinman JW (1972) Production of renomedullary prostaglandins by renomedullary interstitial cells grown in tissue culture. Circ Res 30 and 31 (Suppl II): 161–172

    Google Scholar 

  262. Murray RH, Luft FC, Bloch R, Weyman AE (1978) Blood pressure responses to extremes of sodium intake in normal man. Proc Soc Exp Biol Med 159: 432–436

    PubMed  CAS  Google Scholar 

  263. Naditch MP (1974) Locus of control, relative discontent and hypertension. Soc Psych 9: 111–117

    Article  Google Scholar 

  264. Nasjletti A, McGiffJC, Colina-Chourio J (1978) Interrelations of the renal kallikrein-kinin system and renal prostaglandins in the conscious rat: influence of mineralocorticoids. Circ Res 43: 799–807

    CAS  Google Scholar 

  265. Nestel PJ (1969) Blood pressure and catecholamine excretion after mental stress in labile hypertension. Lancet 1: 692–694

    Article  PubMed  CAS  Google Scholar 

  266. Nestel PJ, Doyle AE (1968) The excretion of free noradrenaline and adrenaline by healthy young subjects and by patients with essential hypertension. Aus Ann Med 17: 295–299

    CAS  Google Scholar 

  267. Nicholls MG, Kiowski W, Zweifler AJ, Julius S, Schork MA, Greenhouse J (1980) Plasma nor-epinephrine variations with dietary sodium intake. Hypertension 2: 29–32

    Article  PubMed  CAS  Google Scholar 

  268. Nies AS (1975) Adverse reactions and interactions limiting the use of antihypertensive drugs. Am J Med 58: 495–503

    Article  PubMed  CAS  Google Scholar 

  269. Noth RH, Mulrow PJ (1976) Serum dopamineß-hydroxylase as an index of sympathetic nervous system activity in man. Circ Res 38: 2–5

    Article  CAS  Google Scholar 

  270. Nustad K, Vaaje K, Pierce JV (1975) Synthesis of kallikrein by rat kidney slices. Brit J Pharmacol 53: 229–234

    Article  CAS  Google Scholar 

  271. Oates JA, Robertson D (1980) The sympathetic nervous system. In: Hunt JC, Cooper T, Frohlich ED, Gifford RW, Kaplan NM, Laragh JH, Maxwell MH, Strong CG (eds) Hypertension update: mechanisms, epidemiology, evaluation, management. Health Learning Systems, Bloomfield, NJ, pp 135–142

    Google Scholar 

  272. Oekler SW, Schöneshöfer M, Schultze G, Brown JJ, Frazer R, Morton JJ, Lever AF, Robertson JIS (1975) Effect of prolonged low-dose angiotensin II infusion on the sensitivity of adrenal cortex in man. Circ Res 36 and 37 (Suppl I): 49–56

    Google Scholar 

  273. Oliver WJ, Cohen EL, Neel JV (1975) Blood pressure, sodium intake and sodium related hormones in the Yanomamo Indians, a „no-salt“ culture. Circulation 52: 146–151

    Article  PubMed  CAS  Google Scholar 

  274. Ondetti MA, Rubin B, Cushman DW (1977) Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents. Science 196: 441–444

    Article  PubMed  CAS  Google Scholar 

  275. Ostergaard K (1977) Cadmium and hypertension. Lancet 1: 677–678

    Article  PubMed  CAS  Google Scholar 

  276. Östman-Smith I (1979) Adaptive changes in the sympathetic nervous system and some effector organs of the rat following long term exercise or cold acclimation and the role of cardiac sympathetic nerves in the genesis of compensatory cardiac hypertrophy. Acta Physiol Scand 477: 1–118

    Google Scholar 

  277. Padfield PL, Beevers DG, Brown JJ, Davies DL, Lever AF, Robertson JIS, Schalekamp MAD, Tree M (1975) Is low-renin hypertension a stage in the development of essential hypertension or a diagnostic entity? Lancet 1: 548–550

    Article  PubMed  CAS  Google Scholar 

  278. Page IH (1949) Pathogenesis of arterial hypertension. JAMA 140: 451–458

    Article  CAS  Google Scholar 

  279. Page IH (1976) Commentary: egregious errors in the management of hypertension. JAMA 236: 2621–2622

    Article  PubMed  CAS  Google Scholar 

  280. Page IH (1977) Some regulatory mechanisms of renovascular and essential arterial hypertension. Chap 12.5 in: Genest J, Koiw E, Kuchel O (eds) Hypertension: physiopathology and treatment. McGraw-Hill, New York, pp 576–587

    Google Scholar 

  281. Page IH (1979) The continuing failure to understand hypertension. JAMA 241: 1897–1898

    Article  PubMed  CAS  Google Scholar 

  282. Page IH, Helmer OM, Kohlstaedt KG, Fouts PJ, Kempf GF, Corcoran AC (1940) Substances in kidneys and muscles eliciting prolonged reduction of blood pressure in human and experimental hypertension. Proc Soc Exp Biol Med 43: 722–728

    CAS  Google Scholar 

  283. Page LB (1978) Salt and hypertension: general discussion. In: Mild hypertension: to treat or not to treat. Ann NY Acad Sci 304: 200

    Google Scholar 

  284. Page LB, Damon A, Moellering RC Jr (1974) Antecedents of cardiovascular disease in six Solomon Island societies. Circulation 49: 1132–1146

    Article  PubMed  CAS  Google Scholar 

  285. Panisset JC, Bourdois P (1968) Effect of angiotensin on the response to noradrenaline and sympathetic nerve stimulation and on 3H-noradrenaline uptake in cat mesenteric blood vessels. Can J Physiol Pharmacol 46: 125–131

    Article  PubMed  CAS  Google Scholar 

  286. Parijs J, Joossens JV, van der Linden L, Verstreken G, Amery AKPC (1973) Moderate sodium restriction and diuretics in the treatment of hypertension. Am Heart J 85: 22–34

    Article  PubMed  CAS  Google Scholar 

  287. Pedersen EB, Christensen NJ (1975) Catecholamines in plasma and urine in patients with essential hypertension determined by double-isotope derivative techniques. Acta Med Scand 198: 373–377

    Article  PubMed  CAS  Google Scholar 

  288. Perera GA (1948) Diagnosis and natural history of hypertensive vascular disease. Am J Med 4: 416–422

    Article  PubMed  CAS  Google Scholar 

  289. Perwitt RL, Leach BE, Byers LW, Brooks B, Lands WEM, Muirhead E (1979) Antihypertensive polar renomedullary lipid, a semisynthetic vasodilator. Hypertension 1: 299–308

    Article  Google Scholar 

  290. Pickering GW (1973) Hypertension: definitions, natural histories and consequences. In: Laragh JH (ed) Hypertension manual: mechanisms, methods, management. Dun-Donnelley, New York, pp 3–30

    Google Scholar 

  291. Pilowsky I, Spalding D, Shaw J, Korner PI (1973) Hypertension and personality. Psychosom Med 35: 50–56

    PubMed  CAS  Google Scholar 

  292. Platt R (1967) The influence of heredity. In: Stamler J, Stamler R, Pullman TN (eds) The epidemiology of hypertension. Grune and Stratton, New York, pp 9–17

    Google Scholar 

  293. Prior IAM, Evans JG, Harvey HPD, Davidson F, Lindsey M (1968) Sodium intake and blood pressure in two Polynesian populations. N Engl J Med 279: 515–520

    Article  PubMed  CAS  Google Scholar 

  294. Rabkin SW, Mathewson FAL, Hsu P-H (1977) Relation of body weight to development of ischemic heart disease in a cohort of young North American men after a 26 year observation period: the Manitoba Study. Am J Cardiol 39: 452–458

    Article  PubMed  CAS  Google Scholar 

  295. Reid JL, Zivin JA, Kopin IJ (1975) Central and peripheral adrenergic mechanisms in the development of deoxycorticosterone-saline hypertension in rats. Circ Res 37: 569–579

    Article  PubMed  CAS  Google Scholar 

  296. Reid JL, Jones DH, Dargie HJ (1977) Plasma noradrenaline and hypertension. Postgrad Med J 53 (Suppl 3): 40–42

    PubMed  CAS  Google Scholar 

  297. Reid JL, Dean CR, Hamilton C, Watson R, Jones DH, Littler W (1978) Relationships between blood pressure, heart rate and plasma nor-adrenaline. In: Birkenhäger WH, Falke HE (eds) Circulating catecholamines and blood pressure. Bunge Scientific Publications. Utrecht, pp 11–16

    Google Scholar 

  298. Reisin E, Abel R, Modan M, Silverberg DS, Eliahou HE, Modan B (1978) Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients. N Engl J Med 298: 1–6

    Article  PubMed  CAS  Google Scholar 

  299. Reit E (1972) Actions of angiotensin on the adrenal medulla and autonomic ganglia. Fed Proc 31: 1338–1343

    PubMed  CAS  Google Scholar 

  300. Remington RD, Lambarth B, Moser M, Hoobler SW (1960). Circulatory reactions of normotensive and hypertensive subjects and the children of normal and hypertensive parents. Am Heart J 59: 58–70

    Article  PubMed  CAS  Google Scholar 

  301. Robertson DH, Johnson GA, Brilis GM, Hill RE, Watson JT, Oates JA (1977) Salt restriction increases serum catecholamines and urinary metanephrine excretion (abstr). Fed Proc 36: 956

    Google Scholar 

  302. Robison GA, Butcher RW, Sutherland EW (1971) Cyclic AMP. Academic Press, New York

    Google Scholar 

  303. Rodicio J (1980) In discussion. In: Hunt JC, Cooper T, Frohlich ED, Gifford RW Jr, Kaplan NM, Laragh JH, Maxell MH, Strong CG (eds) Dialogues in hypertension. Hypertension update: mechanisms, epidemiology, evaluation, management. Health Learning Systems, Bloomfield, NJ, pp 133, 134

    Google Scholar 

  304. Romero JC, Strong CG (1977) The effect of indomethacin blockade of prostaglandin synthesis on blood pressure of normal rabbits and rabbits with renovascular hypertension. Circ Res 40: 35–41

    Article  PubMed  CAS  Google Scholar 

  305. Romoff MS, Keusch G, Campese VM, Wang M-S, Friedler RM, Weidmann P, Massry SG (1978) Effect of sodium intake on plasma catecholamines in normal subjects. J Clin Endocrinol Metab 48: 26–31

    Article  Google Scholar 

  306. Rose RI, Miller JZ, Grim CE, Christian JC, Cardwell GF, Weinberger MH (1978) Aggregation of blood pressure in families of identical twins (abstr 47 ). Annual conference on cardiovascular disease epidemiology, Orlando, Florida

    Google Scholar 

  307. Rosenthal J, Escobar-Jimenez F, Raptis S (1977) Prevention by somatostatin of rise in blood pressure and plasma renin mediated by beta-receptor stimulation. Clin Endocrinol 6: 455–462

    Article  CAS  Google Scholar 

  308. Rosenthal J, Raptis S, Zoupas C, Escobar-Jiminez F (1978) Hemodynamic and renin responses to somatostatin in essential hypertension. Metabolism 27 (Suppl I): 1361–1363

    Article  PubMed  CAS  Google Scholar 

  309. Safar ME, Weiss YA, Leverson JA, London GM, Milliez PL (1973) Hemodynamic study of 85 patients with borderline hypertension. Am J Cardiol 31: 315–319

    Article  PubMed  CAS  Google Scholar 

  310. Safar ME, London GM, Weiss YA, Milliez PL (1975) Vascular reactivity in norepinephrine and hemodynamic parameters in borderline hypertension. Am Heart J 89: 480–486

    Article  PubMed  CAS  Google Scholar 

  311. Safar ME, London GM, Weiss YA, Milliez PL (1976) Neurogenic hyperactivity in borderline hypertension. In: Rorive G (ed) The arterial hypertensive disease. Masson, New York, pp 251–254

    Google Scholar 

  312. Sambhi MP (1977) Activators and inhibitors of renin. Chap 6.8 in: Genest J, Koiw E, Kuchel O (eds) Hypertension: physiopathology and treatment. McGraw-Hill, New York, pp 202–210

    Google Scholar 

  313. Sambhi MP, Eggena P, Barrett JD, Tuck M, Weidman CE, Thananopavarn C (1975) A circulating renin activator in essential hypertension. Circ Res 36 and 37 (Suppl I): 28–37

    Article  Google Scholar 

  314. Sannerstedt R (1966) Hemodynamic response to exercise in patients with arterial hypertension. Acta Med Scand 180 (Suppl 458): 1–83

    Google Scholar 

  315. Sannerstedt R (1969) Hemodynamic findings at rest and during exercise in mild central hypertension. Am J Med Sci 258: 70–79

    Article  PubMed  CAS  Google Scholar 

  316. Satoh S, Zimmerman BG (1975) Influence of the renin-angiotensin system on the effect of prostaglandin synthesis inhibitors in the renal vasculature. Circ Res 36 and 37 (Suppl I): 89–96

    Article  Google Scholar 

  317. Schalekamp MADH, Schalekamp-Kuyken MPA, Birkenhäger WH (1970) Abnormal renal haemodynamics and renin suppression in hypertensive patients. Clin Sci 38: 101–110

    PubMed  CAS  Google Scholar 

  318. Schalekamp MADH, Birkenhäger WH, Zaal GA, Kolsters G (1977) Haemodynamic characteristics of low-renin hypertension. Clin Sci Mol Med 52: 405–412

    PubMed  CAS  Google Scholar 

  319. Schroeder HA (1964) Cadmium hypertension in rats. Am J Physiol 207: 62–66

    PubMed  CAS  Google Scholar 

  320. Sen S, Smeby RR, Bumpus FM (1967) Isolation of a phospholipid renin inhibitor from the kidney. Biochemistry 6: 1572–1581

    Article  PubMed  CAS  Google Scholar 

  321. Sever PS (1978) Catecholamines in essential hypertension: the present controversy. In: Birkenhager WH, Falke HE (eds) Circulating catecholamines and blood pressure. Bunge Scientific Publications, Utrecht, pp 1–10

    Google Scholar 

  322. Sever PS, Osikowska B, Birch M, Tunbridge RDG (1977) Plasma-noradrenaline in essential hypertension. Lancet 1: 1078–1081

    PubMed  CAS  Google Scholar 

  323. Severs WB, Summy-Long J, Daniels-Sever A (1974) Angiotensin interaction with thirst mechanisms. Am J Physiol 226: 340–344

    PubMed  CAS  Google Scholar 

  324. Shepherd JT, Vanhoutte PM (1979) The human cardiovascular system - facts and concepts. Raven Press, New York, p 210

    Google Scholar 

  325. Silbergeld EK, Chisolm JJ Jr (1976) Lead poisoning: altered urinary catecholamine metabolites as indicators of intoxication in mice and children. Science 192: 153–155

    Article  PubMed  CAS  Google Scholar 

  326. Slack BL, Ledingham JM (1976) The influence of sodium intake on the pressor response to angiotensin II in the unanesthetized rat. Clin Sci Mol Med 50: 285–291

    PubMed  CAS  Google Scholar 

  327. Sleight P (1975) Baroreceptor function in hypertension. In: Berglund C, Hanson L, Werkö L (eds) Pathophysiology and management of arterial hypertension. Lindgren A and Sönner AB, Mölndal, Sweden, pp 45–53

    Google Scholar 

  328. Smeby RR, Sen S, Bumpus FM (1967) A naturally occurring renin inhibitor. Circ Res 20 and 21 (Suppl II): 129–134

    Google Scholar 

  329. Stein OC, Hepner R, Greenstreet R (1975) Correlation of blood pressure with skinfold thickness and protein levels. Am J Dis Child 129: 905–911

    Google Scholar 

  330. Stoobandt R, Fagard R, Amery AKPC (1973) Are patients with essential hypertension and low renin protected against stroke and heart attack? Am Heart J 86: 781–787

    Article  Google Scholar 

  331. Susie D, Sparks JC, Machado EA, Kentera D (1978) The mechanism of renomedullary antihypertensive action: haemodynamic studies in hydronephrotic rats with one-kidney renal-clip hypertension. Clin Sci Mol Med 54: 361–367

    Google Scholar 

  332. Swales JD (1975) Low-renin hypertension: nephrosclerosis? Lancet 1: 75–77

    Article  PubMed  CAS  Google Scholar 

  333. Syme SL, Oakes TW, Friedman GD, Feldman R, Siegelaub AB, Collen M (1974) Social class and racial differences in blood pressure. Am J Public Health 64: 619–620

    Article  PubMed  CAS  Google Scholar 

  334. Takahashi E, Sasake N, Takeda J, Ito H (1957) The geographic distribution of cerebral hemorrhage and hypertension in Japan. Hum Biol 29: 139–166

    PubMed  CAS  Google Scholar 

  335. Takeshita A, Tanaka S, Kuroiwa A, Nakamura M (1975) Reduced baroreceptor sensitivity in borderline hypertension. Circulation 51: 738–742

    Article  PubMed  CAS  Google Scholar 

  336. Tan SY, Mulrow PJ (1977) Impaired renal prostaglandin E production: a newly identified lesion in hypertensives. Clin Res 25 (abstr): 450 A

    Google Scholar 

  337. Tarazi RC (1976) Hemodynamic role of extra-cellular fluid in hypertension. Circ Res 38 (Suppl II): 73–83

    Article  PubMed  CAS  Google Scholar 

  338. Tarazi RC, Ibrahim MM, Dustan HP, Ferrario CM (1974) Cardiac factors in hypertension. Circ Res 34 (Suppl I): 213–221

    Google Scholar 

  339. Taylor AA, Pool JL, Lake CR, Ziegler MG, Rosen RA, Rollins DE, Mitchell JR (1978) Plasma norepinephrine concentrations: no differences among normal volunteers and low, high, or normal renin hypertensive patients. Life Sci 22: 1499–1510

    Article  PubMed  CAS  Google Scholar 

  340. Terragno DA, Crowshaw K, Terragno NA, McGiff JC (1975) Prostaglandin synthesis by bovine mesenteric arteries and veins. Circ Res 36 and 37 (Suppl I): 76–80

    Article  Google Scholar 

  341. Thind GS, Fischer GM (1976) Plasma cadmium and zinc in human hypertension. Clin Sci Mol Med 51: 483–486

    PubMed  CAS  Google Scholar 

  342. Thomas CB (1952) The heritage of hypertension. Am J Med Sci 224: 367–376

    Article  PubMed  CAS  Google Scholar 

  343. Tibblin G, Aurell E, Paulin S, Sanne H (1967) High blood pressure and hypertensive disease in men born in 1913. In: Stamler J, Stamler R, Pullman TN (eds) The epidemiology of hypertension. Grune and Stratton, New York, pp 418429

    Google Scholar 

  344. Tobian L (1978) Salt and hypertension. In: Mild hypertension: to treat or not to treat. Ann NY Acad Sci 304: 178–202

    Google Scholar 

  345. Tobian L, Azar S (1971) Antihypertensive and other functions of the renal papilla. Trans Assoc Am Physicians 84: 281–288

    PubMed  Google Scholar 

  346. Tobian L, Binion J (1954) Artery wall electrolytes in renal and DOCA hypertension. J Clin Invest 33: 1407–1414

    Article  PubMed  CAS  Google Scholar 

  347. Tobian L, O’Donnell M (1976) Renal prostaglandins in relation to sodium regulation and hypertension. Fed Proc 35: 2388–2392

    PubMed  CAS  Google Scholar 

  348. Turino PM, Manger WM, Webb KB, Hulse MC, Sussman RG, Forsyth ML, Campbell JP (1980) Effect of NaC1 diet on blood pressure and tissue sodium and potassium in spontaneously hypertensive and normotensive rats (abstr 4837). Fed Proc 39: 1188

    Google Scholar 

  349. Vander AJ (1965) Effect of catecholamines and the renal nerves on renin secretion in anesthetized dogs. Am J Physiol 209: 659–662

    PubMed  CAS  Google Scholar 

  350. Vane JR, McGiff JC (1975) Possible contributions of endogenous prostaglandins to the control of blood pressure. Circ Res 36 and 37 (Suppl 1): 68–75

    Article  Google Scholar 

  351. Vinci J, Zusman R, Bowden R, Horwitz D, Keiser H (1977) Relationship of urinary and plasma kinins to sodium-retaining steroids and plasma renin activity (abstr). Clin Res 25: 450 A

    Google Scholar 

  352. Walker WG, Whelton PK, Saito H, Russell RP, Hermann J (1979) Relation between blood pressure and renin, renin substrate, angiotensin Il, aldosterone and urinary sodium and potassium in 574 ambulatory subjects. Hypertension 1: 287–291

    Article  PubMed  CAS  Google Scholar 

  353. Watkin DM, Froeb HF, Hatch FT, Gutman AB (1950) Effects of diet in essential hypertension. I1. Results with unmodified Kempner rice diet in fifty hospitalized patients. Am J Med 9: 441–493

    Google Scholar 

  354. Webster ME (1970) Kallikreins in glandular tissues. Chap 3 In: Erdös, EG (ed) Handbook of experimental pharmacology, vol XXV. Bradykinin, kallidin and kallikrein. Springer-Verlag, New York, p 131

    Book  Google Scholar 

  355. Weidmann P, Hirsch D, Berett-Piccoli C, Reubi FC, Ziegler WH (1977) Interrelations among blood pressure, blood volume, plasma renin activity and urinary catecholamines in benign essential hypertension. Am J Med 62: 209–218

    Article  PubMed  CAS  Google Scholar 

  356. Weinshilboum RM, Raymond FA, Elveback LR, Weidman WH (1973) Serum dopamine-ßhydroxylase activity: sibling-sibling correlation. Science 181: 943–945

    Article  PubMed  CAS  Google Scholar 

  357. Werko L, Lagerlof H (1949) Studies on the circulation in man. IV. Cardiac output and blood pressure in the right auricle, right ventricle and pulmonary artery in patients with hypertensive cardiovascular disease. Acta Med Scand 133: 427–436

    Google Scholar 

  358. Werning C, Fischer N, Kaip E, Stiel D, Trüben-stein GK, Vetter H (1972) Increased renin stimulation after orthostasis in labile or borderline hypertension. Dtsch Med Wochenschr 97: 1038–1039

    PubMed  CAS  Google Scholar 

  359. Wetterberg L, Aberg H, Ross SB, Frödén Ö (1972) Plasma dopamine-ß-hydroxylase activity in hypertension and various neuropsychiatric disorders. Scand J Clin Lab Invest 30: 283–289

    Article  PubMed  CAS  Google Scholar 

  360. Wheatley D, Baiter M, Levine J, Lipman R, Bauer ML, Bonato R (1975) Psychiatric aspects of hypertension. Brit J Psychiatry 127: 327–336

    Article  CAS  Google Scholar 

  361. Winer N, Carter CH (1978) Plasma norepinephrine response to cold pressor stimulation in normotensive and hypertensive subjects. Clin Res 26: 55 A

    Google Scholar 

  362. Wong PY, Talamo RC, Williams GH, Colman RW (1975) Response of the kallikrein-kinin and renin-angiotensin systems to saline infusion and upright posture. J Clin Inves 55: 691–698

    Article  CAS  Google Scholar 

  363. Yeoman GD, Dustan HP, Tarazi RC, Bravo EL (1976) Hypertension, obesity and blood volume (abstr). Kidney Int 10: 538

    Google Scholar 

  364. Yoshinaga K, Sato T, Ishida N (1960) Studies on the role of noradrenaline in the pathogenesis of hypertension. Tohoku J Exp Med 72: 301–308

    Article  PubMed  CAS  Google Scholar 

  365. Zimmerman BG, Gomer SK, Liao JC (1972) Action of angiotension on vascular adrenergic nerve endings: faciliation of norepinephrine release. Fed Proc 31: 1344–1350

    PubMed  CAS  Google Scholar 

  366. Zinner SH, Levy PS, Kass EH (1971) Familial aggregation of blood pressure in childhood. N Engl J Med 284: 401–404

    Article  PubMed  CAS  Google Scholar 

  367. Zinner SH, Martin LF, Sacks F, Rosner B, Kass EH (1974) A longitudinal study of blood pressure in childhood. Am J Epidemiol 100: 437–442

    PubMed  CAS  Google Scholar 

  368. Zinner SH, Margolius HS, Rasner B, Keiser HR, Kass EH (1976) Familial aggregation of urinary kallikrein concentration in childhood: relation to blood pressure, race and urinary electrolytes. Am J Epidemiol 104: 124–132

    PubMed  CAS  Google Scholar 

  369. Zinner SH, Margolius HS, Rosner BR, Kass EH (1977) Does hypertension begin in childhood? Studies on the familial aggregation of blood pressure in childhood. In: New MI, Levine LS (eds) Juvenile hypertension. Raven Press, New York, pp 45–53

    Google Scholar 

  370. Zinner SH, Margolius HS, Rosner BR, Kass EH (1977) Eight year longitudinal study of blood pressure and urinary kallikrein in childhood (abstr). Res 25: 266 A

    Google Scholar 

Download references

Authors
  1. W. M. Manger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I. H. Page
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Zentrum Innere Medizin, Universität Ulm, Steinhövelstr. 9, D-7900, Ulm, Deutschland

    Julian Rosenthal

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Manger, W.M., Page, I.H. (1984). Zur Pathogenese und Pathophysiologie der essentiellen Hypertonie. In: Rosenthal, J. (eds) Arterielle Hypertonie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-00760-0_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-00760-0_1

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-00761-7

  • Online ISBN: 978-3-662-00760-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation